Literature DB >> 25744102

Malignant progression of precancerous lesions of the uterine cervix following biological DMARD therapy in patients with arthritis.

René Cordtz1, Lene Mellemkjær2, Bente Glintborg1, Merete Lund Hetland3, Lene Dreyer1.   

Abstract

Entities:  

Keywords:  DMARDs (biologic); DMARDs (synthetic); Epidemiology; Infections; Rheumatoid Arthritis

Mesh：

Substances：

Year:  2015        PMID： 25744102     DOI： 10.1136/annrheumdis-2014-206909

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN： 0003-4967            Impact factor:   19.103


× No keyword cloud information.
  5 in total

1.  [Management of inflammatory rheumatic diseases during and after malignancies].

Authors:  Marc Schmalzing
Journal:  Z Rheumatol       Date:  2022-07-07       Impact factor: 1.372

Review 2.  [Gynecological cancers in patients with inflammatory rheumatic diseases].

Authors:  M Schmalzing; M Krockenberger; A Honig; H-P Tony
Journal:  Z Rheumatol       Date:  2016-02       Impact factor: 1.372

Review 3.  The Danish nationwide clinical register for patients with rheumatoid arthritis: DANBIO.

Authors:  Else Helene Ibfelt; Dorte Vendelbo Jensen; Merete Lund Hetland
Journal:  Clin Epidemiol       Date:  2016-10-25       Impact factor: 4.790

4.  Risk of malignancy in rheumatoid arthritis patients initiating biologics: an historical propensity score matched cohort study within the French nationwide healthcare database.

Authors:  Xavier Mariette; Florence Tubach; Raphaele Seror; Alexandre Lafourcade; Yann De Rycke; Sandrine Pinto; Johann Castaneda; Bruno Fautrel
Journal:  RMD Open       Date:  2022-06

5.  Occurrence of an invasive cervical epidermoid carcinoma in a patient receiving TNF-α blocking therapy for hidradenitis suppurativa.

Authors:  Aurélie Ram; Jean-Christophe Noël; Véronique Del Marmol; Farida Benhadou
Journal:  JAAD Case Rep       Date:  2018-10-03
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.